SMARTDM2
醫藥
免費 · 專為 iPad 設計
The management of outpatient antihyperglycemic regimens for patients with type 2 diabetes is complicated. This app is designed to synthesize treatment pathway guidelines developed by the American Diabetes Association, the American Association of Clinical Endocrinologists / American College of Endocrinology, and the Emory University Diabetes Council. Based on patient-specific factors that you select, a weighted list of medication options is sorted and presented.
Designed for use by healthcare professionals. We have no relationship with nor has the app been endorsed by the American Diabetes Association, the American Association of Clinical Endocrinologists or the American College of Endocrinology. Results from the app should not be considered medical advice: individual patient factors not accounted for in the app may influence management decisions; medical evidence and guidelines may change ahead of updates to the app; regardless of best efforts, errors may be present in the app. Consult your doctor before making any changes to your medication regimen.
評分與評論
此App未收到足夠的評分或評論以顯示概況。
Interface updates
開發者Emory University表明App的私隱慣例或包括下列資料的處理。詳情請參閲 開發者的私隱政策 。
不會與你連結的資料
開發者可能會收集以下資料，但不會連結你的個人身份：
- 使用資料
- 診斷
輔助使用
開發者尚未表示此 App 支援哪些輔助使用功能。 進一步了解
資料
- 供應商
- Emory University
- 大小
- 18.9 MB
- 類別
- 醫藥
- 相容性
須使用 iOS 13.4 或以上版本。
- iPhone
須使用 iOS 13.4 或以上版本。 - iPad
須使用 iPadOS 13.4 或以上版本。 - iPod touch
須使用 iOS 13.4 或以上版本。 - Mac
須使用 macOS 11.0 或以上版本及配備 Apple M1 或以上版本晶片的 Mac。 - Apple Vision
須使用 visionOS 1.0 或以上版本。
- 語言
- 英文
- 年齡分級
16+
- 16+
- 頻繁
醫療資訊
- 版權
- © 2024 Emory University